| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
31,932 |
27,628 |
$3.97M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
52,729 |
45,527 |
$3.40M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,309 |
2,060 |
$422K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,053 |
937 |
$413K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,298 |
9,323 |
$388K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,885 |
6,521 |
$326K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
51,597 |
12,993 |
$283K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
808 |
700 |
$259K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,093 |
6,020 |
$220K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,434 |
25,344 |
$167K |
| 71045 |
Radiologic examination, chest; single view |
5,958 |
5,071 |
$166K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,417 |
5,696 |
$163K |
| 80053 |
Comprehensive metabolic panel |
19,832 |
17,188 |
$157K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,732 |
4,156 |
$155K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,252 |
8,709 |
$123K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,391 |
1,983 |
$123K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,330 |
2,226 |
$97K |
| 81025 |
|
14,396 |
12,945 |
$92K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
296 |
266 |
$83K |
| 36415 |
Collection of venous blood by venipuncture |
32,596 |
27,690 |
$65K |
| 59025 |
Fetal non-stress test |
2,023 |
1,152 |
$65K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,174 |
1,011 |
$58K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,187 |
1,059 |
$57K |
| 81001 |
|
21,993 |
19,148 |
$51K |
| 70450 |
Computed tomography, head or brain; without contrast material |
370 |
333 |
$49K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
99 |
95 |
$45K |
| 87081 |
|
10,170 |
6,470 |
$40K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,101 |
1,009 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,014 |
4,358 |
$31K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,505 |
1,293 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,929 |
3,519 |
$25K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
703 |
349 |
$21K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
937 |
476 |
$21K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,248 |
942 |
$20K |
| 87420 |
|
2,060 |
1,531 |
$19K |
| 83690 |
|
3,569 |
3,163 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
808 |
702 |
$19K |
| 95819 |
|
180 |
173 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
293 |
262 |
$13K |
| 84484 |
|
1,424 |
1,132 |
$12K |
| 84145 |
|
647 |
578 |
$12K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
740 |
389 |
$11K |
| 64721 |
|
41 |
39 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
613 |
488 |
$10K |
| 81003 |
|
4,417 |
3,835 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
330 |
317 |
$8K |
| 83605 |
|
795 |
668 |
$7K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
83 |
77 |
$6K |
| G0378 |
Hospital observation service, per hour |
22 |
14 |
$6K |
| 86140 |
|
1,251 |
1,157 |
$5K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
192 |
72 |
$4K |
| 82550 |
|
868 |
789 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$4K |
| 85730 |
|
1,018 |
911 |
$4K |
| 86160 |
|
608 |
297 |
$4K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
413 |
383 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
99 |
89 |
$4K |
| 86038 |
|
314 |
297 |
$3K |
| 85610 |
|
1,073 |
975 |
$3K |
| 87040 |
|
465 |
235 |
$3K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
240 |
212 |
$3K |
| 83735 |
|
598 |
532 |
$3K |
| 86328 |
|
727 |
617 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
15,409 |
7,619 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
158 |
146 |
$2K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
16 |
12 |
$2K |
| 80050 |
General health panel |
63 |
51 |
$2K |
| 84702 |
|
176 |
157 |
$2K |
| 74022 |
|
40 |
39 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
84 |
70 |
$2K |
| 82150 |
|
389 |
334 |
$2K |
| 86480 |
|
29 |
29 |
$2K |
| 83880 |
|
54 |
50 |
$2K |
| 85651 |
|
471 |
443 |
$2K |
| 85379 |
|
206 |
192 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
55 |
52 |
$1K |
| 94760 |
|
1,501 |
1,315 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
30 |
29 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
20 |
13 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14 |
13 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
22 |
15 |
$1K |
| 87807 |
|
71 |
63 |
$885.63 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
33 |
25 |
$824.05 |
| 86850 |
|
520 |
407 |
$778.68 |
| 80061 |
Lipid panel |
72 |
59 |
$737.77 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
719 |
600 |
$732.22 |
| 87186 |
|
95 |
86 |
$663.15 |
| 87077 |
|
94 |
88 |
$652.11 |
| 73620 |
|
23 |
12 |
$638.44 |
| 73560 |
|
23 |
12 |
$638.44 |
| 73130 |
|
23 |
12 |
$638.44 |
| 59430 |
|
16 |
15 |
$597.30 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
240 |
177 |
$589.17 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
717 |
602 |
$588.50 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
74 |
59 |
$534.65 |
| 84439 |
|
78 |
64 |
$524.06 |
| 84165 |
|
53 |
53 |
$516.84 |
| 86200 |
|
41 |
41 |
$506.48 |
| 73521 |
|
14 |
12 |
$460.35 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
126 |
123 |
$440.59 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$428.89 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$428.89 |
| 82553 |
|
54 |
45 |
$349.97 |
| 84703 |
|
71 |
60 |
$320.00 |
| 72040 |
|
14 |
12 |
$319.22 |
| 86901 |
|
453 |
355 |
$318.41 |
| 86900 |
|
453 |
355 |
$318.41 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
63 |
62 |
$316.13 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
341 |
319 |
$239.04 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
12 |
12 |
$157.70 |
| 84550 |
|
29 |
29 |
$122.34 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
25 |
12 |
$103.68 |
| 84155 |
|
55 |
53 |
$99.53 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
18 |
15 |
$98.34 |
| 87340 |
|
15 |
15 |
$93.47 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
18 |
12 |
$81.35 |
| 86431 |
|
14 |
14 |
$79.62 |
| 83615 |
|
14 |
14 |
$78.64 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
975 |
622 |
$63.28 |
| J2704 |
Injection, propofol, 10 mg |
85 |
79 |
$45.47 |
| C1769 |
Guide wire |
25 |
12 |
$44.34 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13 |
13 |
$25.19 |
| 97010 |
|
132 |
39 |
$19.18 |
| A4351 |
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
352 |
332 |
$8.82 |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
18 |
12 |
$8.76 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
15 |
15 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
505 |
479 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
97 |
42 |
$0.00 |
| A9270 |
Non-covered item or service |
16 |
13 |
$0.00 |
| L8699 |
Prosthetic implant, not otherwise specified |
27 |
27 |
$0.00 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
45 |
40 |
$0.00 |
| 99152 |
|
168 |
100 |
$0.00 |
| 69990 |
|
119 |
47 |
$0.00 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
15 |
13 |
$0.00 |
| 87339 |
|
12 |
12 |
$0.00 |